Ameriprise’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.77M | Sell |
167,006
-16,590
| -9% | -$369K | ﹤0.01% | 2619 |
|
|
2025
Q4 | $4.75M | Sell |
183,596
-19,622
| -10% | -$467K | ﹤0.01% | 2467 |
|
|
2025
Q3 | $5.24M | Sell |
203,218
-123,541
| -38% | -$3.03M | ﹤0.01% | 2416 |
|
|
2025
Q2 | $7.81M | Sell |
326,759
-29,052
| -8% | -$732K | ﹤0.01% | 2006 |
|
|
2025
Q1 | $8.84M | Buy |
355,811
+31,550
| +10% | +$755K | ﹤0.01% | 1849 |
|
|
2024
Q4 | $6.11M | Buy |
324,261
+194,597
| +150% | +$3.42M | ﹤0.01% | 2212 |
|
|
2024
Q3 | $1.95M | Sell |
129,664
-58,293
| -31% | -$997K | ﹤0.01% | 2931 |
|
|
2024
Q2 | $5.38M | Sell |
187,957
-18,055
| -9% | -$514K | ﹤0.01% | 2248 |
|
|
2024
Q1 | $6.02M | Sell |
206,012
-8,617
| -4% | -$265K | ﹤0.01% | 2222 |
|
|
2023
Q4 | $7.24M | Sell |
214,629
-11,515
| -5% | -$337K | ﹤0.01% | 2059 |
|
|
2023
Q3 | $6.94M | Sell |
226,144
-19,958
| -8% | -$719K | ﹤0.01% | 2018 |
|
|
2023
Q2 | $9.86M | Sell |
246,102
-12,864
| -5% | -$532K | ﹤0.01% | 1782 |
|
|
2023
Q1 | $10.6M | Buy |
258,966
+1,957
| +0.8% | +$77.9K | ﹤0.01% | 1729 |
|
|
2022
Q4 | $9.92M | Sell |
257,009
-52,227
| -17% | -$2.54M | ﹤0.01% | 1746 |
|
|
2022
Q3 | $16.4M | Sell |
309,236
-2,308
| -0.7% | -$128K | 0.01% | 1303 |
|
|
2022
Q2 | $18.2M | Buy |
311,544
+54,457
| +21% | +$3.57M | 0.01% | 1275 |
|
|
2022
Q1 | $19.6M | Buy |
257,087
+432
| +0.2% | +$28.8K | 0.01% | 1363 |
|
|
2021
Q4 | $15.4M | Sell |
256,655
-41,279
| -14% | -$2.28M | ﹤0.01% | 1612 |
|
|
2021
Q3 | $16.7M | Sell |
297,934
-41,425
| -12% | -$2.39M | 0.01% | 1413 |
|
|
2021
Q2 | $20.6M | Sell |
339,359
-4,849
| -1% | -$307K | 0.01% | 1331 |
|
|
2021
Q1 | $24.1M | Buy |
344,208
+74,674
| +28% | +$5.33M | 0.01% | 1184 |
|
|
2020
Q4 | $16.1M | Buy |
269,534
+29,899
| +12% | +$1.75M | 0.01% | 1391 |
|
|
2020
Q3 | $14.4M | Buy |
239,635
+5,389
| +2% | +$313K | 0.01% | 1289 |
|
|
2020
Q2 | $12.3M | Buy |
234,246
+18,907
| +9% | +$790K | 0.01% | 1376 |
|
|
2020
Q1 | $7.22M | Sell |
215,339
-2,100
| -1% | -$87.2K | ﹤0.01% | 1638 |
|
|
2019
Q4 | $9.85M | Sell |
217,439
-3,795
| -2% | -$161K | ﹤0.01% | 1753 |
|
|
2019
Q3 | $8.42M | Buy |
+221,234
| New | +$8.83M | ﹤0.01% | 1839 |
|
|
2019
Q2 | – | Sell |
-92,040
| Closed | -$3.5M | – | 3769 |
|
|
2019
Q1 | $3.5M | Sell |
92,040
-817
| -0.9% | -$31.9K | ﹤0.01% | 2449 |
|
|
2018
Q4 | $4M | Buy |
92,857
+44,181
| +91% | +$2.06M | ﹤0.01% | 2268 |
|
|
2018
Q3 | $2.39M | Sell |
48,676
-1,929
| -4% | -$83.4K | ﹤0.01% | 2748 |
|
|
2018
Q2 | $1.62M | Sell |
50,605
-118,263
| -70% | -$4.08M | ﹤0.01% | 2810 |
|
|
2018
Q1 | $5.26M | Sell |
168,868
-120,716
| -42% | -$4.3M | ﹤0.01% | 2140 |
|
|
2017
Q4 | $13.2M | Sell |
289,584
-694
| -0.2% | -$27.5K | 0.01% | 1387 |
|
|
2017
Q3 | $10.9M | Sell |
290,278
-29,741
| -9% | -$1.2M | 0.01% | 1504 |
|
|
2017
Q2 | $15.3M | Buy |
320,019
+37,488
| +13% | +$1.74M | 0.01% | 1225 |
|
|
2017
Q1 | $12.9M | Buy |
282,531
+250,714
| +788% | +$10.8M | 0.01% | 1336 |
|
|
2016
Q4 | $1.03M | Sell |
31,817
-121,305
| -79% | -$4.05M | ﹤0.01% | 2962 |
|
|
2016
Q3 | $5.24M | Sell |
153,122
-85,624
| -36% | -$3.35M | ﹤0.01% | 1949 |
|
|
2016
Q2 | $8.05M | Buy |
238,746
+40,183
| +20% | +$1.97M | ﹤0.01% | 1572 |
|
|
2016
Q1 | $10.5M | Buy |
198,563
+127,174
| +178% | +$7.44M | 0.01% | 1374 |
|
|
2015
Q4 | $5.49M | Sell |
71,389
-934,738
| -93% | -$52.9M | ﹤0.01% | 1947 |
|
|
2015
Q3 | $41.3M | Buy |
1,006,127
+133,529
| +15% | +$8.18M | 0.03% | 564 |
|
|
2015
Q2 | $61.7M | Sell |
872,598
-58,938
| -6% | -$4.64M | 0.04% | 446 |
|
|
2015
Q1 | $82.8M | Buy |
931,536
+91,013
| +11% | +$9.23M | 0.05% | 367 |
|
|
2014
Q4 | $74.5M | Buy |
840,523
+108,326
| +15% | +$10.2M | 0.04% | 397 |
|
|
2014
Q3 | $71M | Buy |
732,197
+211,652
| +41% | +$20.6M | 0.04% | 415 |
|
|
2014
Q2 | $47.8M | Buy |
520,545
+171,365
| +49% | +$13M | 0.03% | 554 |
|
|
2014
Q1 | $24.4M | Buy |
349,180
+32,940
| +10% | +$2.24M | 0.01% | 871 |
|
|
2013
Q4 | $18.2M | Buy |
316,240
+83,540
| +36% | +$4.39M | 0.01% | 1060 |
|
|
2013
Q3 | $11.2M | Buy |
232,700
+195,527
| +526% | +$7.13M | 0.01% | 1385 |
|
|
2013
Q2 | $1.08M | Buy |
+37,173
| New | +$1.08M | ﹤0.01% | 2582 |
|
Other funds holding PCRX
DPCM
VPM
VCM
Ameriprise's PCRX Position: Q1 2026 in Review
Ameriprise reduced its Pacira BioSciences (PCRX) stake by 9% in Q1 2026, selling an estimated $369K and leaving 167,006 shares worth $3.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2619.
Ameriprise first reported a position in PCRX in Q2 2013 and has held it in 51 quarters since. The position peaked at $82.8M in Q1 2015. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.
- Ameriprise held 167,006 shares of Pacira BioSciences worth $3.77M as of Q1 2026.
- Ameriprise sold 16,590 Pacira BioSciences shares in Q1 2026, an estimated $369K.
- Pacira BioSciences made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2619 holding.
- Ameriprise first reported a position in Pacira BioSciences in Q2 2013 and has held it in 51 quarters since.
- Ameriprise's Pacira BioSciences position peaked at $82.8M in Q1 2015.
- 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.